The IBEX 35 (SPA35) index is the biggest gainer among the major Western European stock market benchmarks in March, outperforming Italy's FTSE MIB (ITA40).
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appRate of return for individual stock market indexes. Source: Bloomberg Financial LP
Banks, the IBEX's largest industry group, led the rise with more than 30%.
Return on shares of individual representatives of the European banking sector for March. We saw the largest increases in the stocks of Santander (SAN1.ES) and ING (INGA.NL). Source: xStation
Banks benefited from higher interest rates, which, however, may be leaning towards a change. On the other hand, however, increased shareholder returns may provide some support for the sector. Last week, Santander said it was considering making more than €6 billion worth of dividend payments and share buybacks after an "excellent" start to 2024.
The index is trading at a 20% discount to the Stoxx 600 index, well below its 10-year average. Source: Bloomberg Financial LP
However, looking at the momentum of recent moves, the window for sizable rallies may now be shrinking. The RSI indicator for the weekly interval has broken out above the textbook overbought zone. Source: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.